| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |